ClinicalTrials.Veeva

Menu

Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality

G

Gulhane School of Medicine

Status

Enrolling

Conditions

Multiple Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT07374237
08/1454

Details and patient eligibility

About

Multiple sclerosis (MS) is a chronic disease of the central nervous system associated with a wide range of motor and non-motor symptoms. Sleep disturbances, fatigue, altered interoceptive perception, and impairments in upper and lower extremity functional capacity are commonly observed in individuals with MS. Decreased sleep quality may exacerbate fatigue and negatively affect daily activities and independence. Therefore, examining the relationships between sleep quality, interoception, fatigue, and extremity functional capacity is essential for effective disease management and the preservation of quality of life in individuals with MS.

The aim of this study is to compare interoception, fatigue, and upper and lower extremity functional capacity between individuals with MS who have good and poor sleep quality and to evaluate the relationships among these variables. By comparing MS patients based on sleep quality, this study seeks to clarify the impact of sleep quality on interoceptive processes, fatigue levels, and functional capacity.

Enrollment

102 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with multiple sclerosis by a specialist physician
  • Aged between 18 and 65 years
  • No MS relapse within the last 3 months
  • Expanded Disability Status Scale (EDSS) score between 1.0 and 5.0
  • Ability to stand independently for at least 60 seconds without the use of any assistive device
  • No additional neurological disorder or circulatory/visual impairment that may affect balance
  • Cognitive function score >24 on the Mini-Mental State Examination (MMSE)
  • Provided written informed consent after receiving detailed information about the study

Exclusion criteria

  • Use of corticosteroids within the last 4 weeks
  • Pregnancy
  • Presence of spinal deformities, disc herniation, or other spinal pathologies
  • Presence of orthopedic conditions affecting the hip, knee, or ankle
  • History of surgery involving the spine, hip, knee, or ankle
  • Change in medication within the last month

Trial design

102 participants in 2 patient groups

Multiple Sclerosis Patients with Poor Sleep Quality
Description:
Participants with a Pittsburgh Sleep Quality Index (PSQI) total score of 5 or higher, indicating poor sleep quality.
Multiple Sclerosis Patients with Poor Good Quality
Description:
Good sleep quality group: Participants with a Pittsburgh Sleep Quality Index (PSQI) total score below 5, indicating good sleep quality.

Trial contacts and locations

1

Loading...

Central trial contact

Ozge Ozkutlu, Assistant Professor; Saime Busranur Polat, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems